Welcome to the latest issue of Clinical Risk Insights brought to you by the Clinical Risk Unit of the State Claims Agency (SCA). In this issue, you will find articles on why clinical claims occur and how to avoid them, recording and documentation in the healthcare record and on the risks presented by insulin and how to mitigate against them.
In this issue
Editorial
Cathal O’Keeffe, Head of Clinical Risk, reflects on the recent surge in the Omicron variant of COVID-19 and its impact on the delivery of healthcare, and highlights some of the key themes from the State Claim Agency's Quality, Clinical Risk and Patient Safety series which took place throughout 2021.
Read article
Why clinical claims occur and how to avoid them
In this article, Dr Karen Power examines some of the common features seen in the State Claims Agency’s portfolio of clinical claims.
Read article
Recording and documentation in the Healthcare Record
In this article, Natasha Coen and Mary Godfrey from the SCA’s Clinical Risk Unit outline the issues with recording and documentation in the Healthcare Record (HCR) and provide advice for safe practice.
Read article
Insulin: a high-risk medication
In this article, Mark McCullagh, Clinical Risk Adviser, takes a look at the risks presented by insulin and what healthcare organisations can do to reduce insulin-related patient harm.
Read article
NIMS updates
An update on changes to the categorisation of clinical care incidents on NIMS, the National Incident Management System.
Read article
Clinical Risk Insights
Clinical Risk Insights is the regular newsletter issued by the Clinical Risk Unit of the State Claims Agency for health and social care workers in Ireland. View past editions of Clinical Risk Insights.
